BIOMARIN PHARMACEUTICAL Stock Quote

$99.05 arrow  Change: -2.07 %Chge: -2.05% Vol: 30,705
End Of Day Prices
High: 101.32 | Low: 98.87 | Open: 101.32 | Close: 99.05
52 Wk High: 106.06 | 52 Wk Low: 75.94 | Todays Pivot: 99.75
Sector: Healthcare and Pharmaceuticals add stock to watch list

BMRN Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Owens & Minor 29.01 green arrow 62,129
Mednax 71.34 green arrow 24,803
Endo Pharmaceuticals Hldgs 16.47 red arrow 98,082
Alexion Pharmaceuticals 119.37 green arrow 59,885
Perkinelmer 54.48 green arrow 46,429
Alere 48.805 green arrow 60,844
Mckesson 72.99 green arrow 98,530
Thermo Fisher Scientific 64.8 green arrow 296,168

Above is a small selection of related companies to Biomarin Pharmaceutical which compete alongside BMRN within the Healthcare and Pharmaceuticals sector. To see more related companies to BMRN, view our stock market today information page.

Online News For Biomarin Pharmaceutical

Rhumbline Advisers Has $18.30 Million Stake in BioMarin Pharmaceutical Inc. (BMRN)

Rhumbline Advisers decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 4.0% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 194,253 shar...


BioMarin Pharmaceutical Inc. (BMRN) Given Average Recommendation of “Buy” by Brokerages

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has received an average rating of “Buy” from the twenty-one analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst ha...


BioMarin Pharmaceutical (NASDAQ:BMRN) Receives “Hold” Rating from Barclays

Barclays restated their hold rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN) in a research note issued to investors on Sunday, August 5th. Barclays currently has a $98.00 price target on the ...


BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 7.9%

BioMarin Pharmaceutical Inc. (BMRN - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing ...


Is there a Bearish outlook for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) this week?

Investors sentiment decreased to 0.96 in 2018 Q1. Its down 0.25, from 1.21 in 2017Q4. It worsened, as 38 investors sold BioMarin Pharmaceutical Inc. shares while 124 reduced holdings. 36 funds opened ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Biomarin Pharmaceutical quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BMRN to choose from. Visit here to build your stock quote widget »